For its fourth fiscal quarter (ending December 31), Nasdaq Inc (NASDAQ: NDAQ) has reported a 72% increase in E.P.S. from $0.36 a year ago to $0.62 in the current quarter. E.P.S. were $1.94 for the […]
Lennox International Inc. (NYSE: LII) has reported earnings for its fourth fiscal quarter (ending December 31) of $5.55 versus $4.07 for the same period a year ago — an increase of 36%. For the latest […]
For its first fiscal quarter (ending December 31), Dolby Laboratories Inc (NYSE: DLB) has reported a 1% increase in E.P.S. from $0.70 a year ago to $0.71 in the current quarter. E.P.S. were $2.74 for […]
For its fourth fiscal quarter (ending December 31), Danaher Corp (NYSE: DHR) has reported a -1% decline in E.P.S. from $1.52 a year ago to $1.50 in the current quarter. E.P.S. were $5.33 for the […]
Central Pacific Financial Corp. (NYSE: CPF) has reported E.P.S. of $0.42 for its fourth fiscal quarter (ending December 31) versus $0.55 for the same period a year ago — a decline of -24%. For the […]
Celestica Inc (NYSE: CLS) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.30 versus $0.71 for the same period a year ago — an increase of 83%. For the latest four […]
For its first fiscal quarter (ending December 31), Capitol Federal Financial Inc (NASDAQ: CFFN) has reported a 500% increase in E.P.S. from $0.02 a year ago to $0.12 in the current quarter. E.P.S. were $0.39 […]
For its fourth fiscal quarter (ending December 31), Calix Inc (NYSE: CALX) has reported a 170% increase in E.P.S. from $-0.10 a year ago to $-0.27 in the current quarter. For the latest four quarters […]
Xerox Holdings Corp (NASDAQ: XRX) has reported E.P.S. of $-0.20 for its fourth fiscal quarter (ending December 31) versus $-0.50 for the same period a year ago — a decline of -60%. For the latest […]
For its fourth fiscal quarter (ending December 31), Synchrony Financial (NYSE: SYF) has reported a 86% increase in E.P.S. from $1.04 a year ago to $1.93 in the current quarter. For the latest four quarters […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research